Proteome Sciences plc (LON:PRM – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 1.56 and traded as high as GBX 1.60. Proteome Sciences shares last traded at GBX 1.60, with a volume of 313,591 shares.
Proteome Sciences Stock Performance
The company has a market capitalization of £5.79 million, a P/E ratio of -1.59 and a beta of 0.17. The stock’s fifty day moving average price is GBX 1.58 and its 200-day moving average price is GBX 1.89. The company has a debt-to-equity ratio of -165.46, a quick ratio of 0.37 and a current ratio of 0.13.
Proteome Sciences (LON:PRM – Get Free Report) last posted its quarterly earnings results on Wednesday, April 15th. The company reported GBX (1.04) EPS for the quarter. The business had revenue of GBX 376 million for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
